Skip to main content

and
  1. No Access

    Article

    Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab

    The aim of this study is to evaluate the influence of germline vascular endothelial growth factor (VEGF) gene polymorphisms (VGPs) on the efficacy of the anti-VEGF antibody bevacizumab (Bev) in metastatic colo...

    Vincenzo Formica, Raffaele Palmirotta in International Journal of Colorectal Disease (2011)

  2. Article

    Open Access

    Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells

    Breast cancer (BC) cells secrete soluble factors that accelerate osteoclast (OC) differentiation, leading to the formation of osteolytic bone metastases. In the BOLERO-2 trial, BC patients with bone involvemen...

    Valeria Simone, Sabino Ciavarella, Oronzo Brunetti, Annalisa Savonarola in BMC Cancer (2015)